PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)

NCT02723877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: PQR309
DRUG: Eribulin

Sponsor

PIQUR Therapeutics AG

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]